Skip to content

East River Medical Imaging Selected as First BAMF RadioNexus Site in the New York City Area

Partnership brings new cancer trial and treatments to patients in New York City and Westchester.

Read more

September 9, 2025

Prostate Cancer Patients Now Have an Option Other Than Chemotherapy

Prostate cancer patients whose cancer has spread have a game-changing new option for treatment.

Read more

May 12, 2025

BAMF Health Doses First Patient in the U.S. in Phase 2b Imaging Study of Brain Metastasis

BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.

Read more

April 28, 2025

BAMF Health seeks breast cancer patients for groundbreaking imaging study

This non-invasive clinical trial aims to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.

Read more

April 24, 2025

Celebrating World Theranostics Day 2025

BAMF Health Chief Medical Advisor Dr. Harshad Kulkarni shares his expert perspectives on the field of Theranostics and where it’s headed.

Read more

March 28, 2025

A Holiday Health Scare Leads to Rare Discovery

Mike credits the radiopharmaceutical therapy he received at BAMF for shrinking his neuroendocrine tumor and saving his life.

Read more

March 27, 2025

Reeling in a Brighter Future

After a decades-long battle with neuroendocrine cancer, Nolan hopes treatment at BAMF Health will stop his cancer in its tracks.

Read more

March 24, 2025

PET Imaging Pioneer Dr. Abass Alavi Makes $100K Donation to BAMF Health Foundation (FMAB)

Dr. Abass Alavi, a pioneering figure in the field of molecular imaging and nuclear medicine, and his wife Jane Alavi, made a $100,000 donation to our Foundation.

Read more

February 13, 2025

Infused with Possibility: Alzheimer’s Patient Shares Treatment Experience

BAMF Alzheimer’s patient says he feels privileged to come here and adds, “Now I have a shot.”

Read more

February 4, 2025

Fueled by Hope and the Open Road

David was the first person in the United States to receive a new experimental agent to treat pancreatic cancer.

Read more

January 22, 2025